End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,55,930 CLP | 0.00% | 0.00% | +14.33% |
03:23pm | Johnson & Johnson's Balversa Gets EU Panel Recommendation for Urothelial Carcinoma | MT |
08:00am | Dealmakers optimistic on global M&A prospects despite sluggish growth | RE |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- JNJ Stock
- JNJCL Stock
- Revisions Johnson & Johnson